Title 42, The Public Health and WelfareRelease 119-110

§287d–1 National Data System and Clearinghouse on Research on Women’s Health

Title 42 › CHAPTER 6A — PUBLIC HEALTH SERVICE › SUBCHAPTER III — NATIONAL RESEARCH INSTITUTES › Part F — Research on Women’s Health › § 287d–1

Last updated Sep 22, 2026|Official source

Summary

The NIH Director, working with the Director of the Office and the Director of the National Library of Medicine, must set up a data system to collect, store, study, and share information about women’s health research done or funded by the national research institutes. Doctors, researchers, and the public must be able to access the information. The system must include a clinical trial registry with eligibility rules, sex, age, race or ethnicity, and trial locations. Lead researchers must send this data within 30 days after it is available and must report results, including any toxicities or adverse effects, when a trial ends. The NIH Director must also run a clearinghouse to share information on research and prevention related to women’s health.

Full Legal Text

Title 42, §287d–1

The Public Health and Welfare, Source: USLM XML via OLRC

(a)Data system

(1)The Director of NIH, in consultation with the Director of the Office and the Director of the National Library of Medicine, shall establish a data system for the collection, storage, analysis, retrieval, and dissemination of information regarding research on women’s health that is conducted or supported by the national research institutes. Information from the data system shall be available through information systems available to health care professionals and providers, researchers, and members of the public.

(2)The data system established under paragraph (1) shall include a registry of clinical trials of experimental treatments that have been developed for research on women’s health. Such registry shall include information on subject eligibility criteria, sex, age, ethnicity or race, and the location of the trial site or sites. Principal investigators of such clinical trials shall provide this information to the registry within 30 days after it is available. Once a trial has been completed, the principal investigator shall provide the registry with information pertaining to the results, including potential toxicities or adverse effects associated with the experimental treatment or treatments evaluated.

(b)Clearinghouse

The Director of NIH, in consultation with the Director of the Office and with the National Library of Medicine, shall establish, maintain, and operate a program to provide information on research and prevention activities of the national research institutes that relate to research on women’s health.

Reference

Citations & Metadata

Citation

42 U.S.C. § 287d–1

Title 42, The Public Health and Welfare

Last Updated

Sep 22, 2026

Release point: 119-110